Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 256 AL 270

Potential roles of brain barrier dysfunctions in the early stage of Alzheimer's disease

Jian WX, Zhang Z, Chu SF, Peng Y, Chen NH.

Brain Res Bull. 2018 Sep;142:360-367. doi: 10.1016/j.brainresbull.2018.08.012. Epub 2018 Aug 25.

Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease

Junges VM, Closs VE, Nogueira GM, Gottlieb MGV.

Curr Alzheimer Res. 2018;15(13):1179-1190. doi: 10.2174/1567205015666180904155908.

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression

Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.

F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.

Rodent models for Alzheimer disease

Götz J, Bodea LG, Goedert M.

Nat Rev Neurosci. 2018 Oct;19(10):583-598. doi: 10.1038/s41583-018-0054-8.

Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study

Koychev I, Galna B, Zetterberg H, Lawson J, Zamboni G, Ridha BH, Rowe JB, Thomas A, Howard R, Malhotra P, Ritchie C, Lovestone S, Rochester L.

J Alzheimers Dis. 2018;65(4):1377-1383. doi: 10.3233/JAD-180622.

The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View

Penke B, Paragi G, Gera J, Berkecz R, Kovács Z, Crul T, VÍgh L.

Curr Alzheimer Res. 2018;15(13):1191-1212. doi: 10.2174/1567205015666180911151716.

Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease

Lei Y, Renyuan Z.

Endocrinology. 2018 Dec 1;159(12):3885-3894. doi: 10.1210/en.2018-00660.

An MRI biomarker of mixed pathology

Bennett DA.

Neurology. 2018 Oct 9;91(15):682-683. doi: 10.1212/WNL.0000000000006305. Epub 2018 Sep 14.

An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

Brickman AM, Tosto G, Gutierrez J, Andrews H, Gu Y, Narkhede A, Rizvi B, Guzman V, Manly JJ, Vonsattel JP, Schupf N, Mayeux R.

Neurology. 2018 Oct 9;91(15):e1402-e1412. doi: 10.1212/WNL.0000000000006310. Epub 2018 Sep 14.

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Ide K, Matsuoka N, Yamada H, Furushima D, Kawakami K.

Molecules. 2018 Sep 14;23(9):2357. doi: 10.3390/molecules23092357.

Oxidative stress in Alzheimer disease as a target for therapy

Pohanka M.

Bratisl Lek Listy. 2018;119(9):535-543. doi: 10.4149/BLL_2018_097.

Aβ and the dementia syndrome: Simple versus complex perspectives

Hunter S, Smailagic N, Brayne C.

Eur J Clin Invest. 2018 Dec;48(12):e13025. doi: 10.1111/eci.13025. Epub 2018 Oct 4.

Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease

Ihara R, Vincent BD, Baxter MR, Franklin EE, Hassenstab JJ, Xiong C, Morris JC, Cairns NJ.

Ann Neurol. 2018 Nov;84(5):741-753. doi: 10.1002/ana.25344. Epub 2018 Oct 25.

Mass spectrometry analysis of the diversity of Aβ peptides: difficulties and future perspectives for AD biomarker discovery

Zakharova NV, Bugrova AE, Kononikhin AS, Indeykina MI, Popov IA, Nikolaev EN.

Expert Rev Proteomics. 2018 Oct;15(10):773-775. doi: 10.1080/14789450.2018.1525296. Epub 2018 Sep 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias